Cyclic nucleotides and inducible nitric oxide synthesis in pulmonary artery smooth muscle

Journal of Surgical Research

Volumn 82, Issue 2, 1999, Pages 222-227

  Hayden, Melissa A ^a   Nakayama, Don K ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Histology; Ischemia; Kidney; Proximal tubule; Transplantation

Indexed keywords

8 BROMO CYCLIC GMP; BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC NUCLEOTIDE; INTERLEUKIN 1BETA; KT 5720; KT 5823; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 0032864190     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5573     Document Type: Article

References (36)

1. Arnold W. P., Mittal C. K., Katsuki S., Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. USA. 74:1977;3203.
2. Schmidt H. H. H. W., Lohmann S. M., Walter U. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim. Biophys. Acta. 1178:1993;153.
3. Moro M. A., Russell R. J., Cellek S., Lizasoain I., Su Y., Darley-Usmar V. M., Radomski M. W., Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. USA. 93:1996;1480.
4. Lincoln T. M., Cornwell T. L. Intracellular cyclic GMP receptor proteins. FASEB J. 7:1993;328.
5. ++. Proc. Natl. Acad. Sci. USA. 89:1992;1031.
6. Archer S. L., Huang J. M. C., Hampl V., Nelson D. P., Shultz P. J., Weir E. K. Nitric oxide and cGMP cause vasorelaxation by activation of a chrybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 91:1994;7583.
7. Taylor S. S., Buechler J. A., Yonemoto W. cAMP-dependent protein kinase: Framework for a diverse family of regulatory enzymes. Annu. Rev. Biochem. 59:1990;971.
8. Inoue T., Fukuo K., Nakahashi T., Hata S., Morimoto S., Ogihara T. cGMP upregulates nitric oxide synthase expression in vascular smooth muscle cells. Hypertension. 25:1995;711.
9. Durante W., Cheng K., Shaefer A. I. Cyclic nucleotide regulation of interleukin-1β induced nitric oxide synthase expression in vascular smooth muscle cells. Thromb. Res. 75:1994;63.
10. Scott-Burden T., Elizondo E., Ge T., Boulanger C. M., Vanhoutte P. M. Simultaneous activation of adenylyl cyclase and protein kinase C induces production of nitric oxide by vascular smooth muscle cells. Mol. Pharmacol. 46:1994;274.
11. Hirokawa K., O'Shaughnessy K., Moore K., Ramrakha P., Wilkins M. R. Induction of nitric oxide synthase in cultured vascular smooth muscle cells: The role of cyclic AMP. Br. J. Pharmacol. 112:1994;396.
12. Papapetropoulos A., Marczin N., Mora G., Milici A., Murad F., Catravas J. D. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents. Hypertension. 26:1995;696.
13. Cornwell T. L., Arnold E., Boerth N. J., Lincoln A. M. Inhibition of smooth muscle growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 267:1994;C1405.
14. Barnes P. J. Cyclic nucleotides and phosphodiesterases and airway function. Eur. Respir. J. 8:1995;457.
15. Marletta M. A., Yoon P. S., Iyengar R., Leaf C. D., Wishnok J. S. Macrophage oxidation ofl. Biochemistry. 27:1988;8706.
16. Curran R. D., Billiar T. R., Stuehr D. J., Hofmann K., Simmons R. L. Hepatocytes produce nitrogen oxides froml. J. Exp. Med. 170:1989;1769.
17. Nakayama D. K., Geller D. A., Lowenstein C. J., Davies P., Pitt B. R., Simmons R. L., Billiar T. R. Cytokines and lipopolysaccharide induce nitric oxide synthase in cultured rat pulmonary artery smooth muscle. Am. J. Respir. Cell Mol. Biol. 7:1992;471.
18. Ochoa J. B., Udekwu A. O., Billiar T. R., Curran R. D., Cerra F. B., Simmons R. L., Peitzman A. B. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 214:1991;621.
19. Billiar T. R., Curran R. D., Harbrecht B. G., Stadler J., Williams D. L., Ochoa J. B., Di Silvio M., Simmons R. L., Murray S. A. Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes. Am. J. Physiol. 262:1992;C1077.
20. Lorente J. A., Landin L., Renes E., de Pablo R., Jorge P., Rodena E., Liste D. Role of nitric oxide in the hemodynamic changes of sepsis. Crit. Care Med. 21:1993;759.
21. Schramm M., Selinger Z. Message transmission: Receptor controlled adenylate cyclase system. Science. 225:1984;1350.
22. Brenner C. A., Tam A. W., Nelson P. A., Engleman E. G., Suzuki N., Fry K. E., Larrick J. W. Message amplification phenotyping (MAPPing): A technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques. 7:1989;1096.
23. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156.
24. Pradelles P., Grassi J., Chabarges N. Enzyme immunoassays of adenosine cyclic 3′-5′ monophosphate and guanosine cyclic 3′-5′ monophosphate using acetylcholinesterase. Anal. Chem. 61:1989;447.
25. Sowa G., Przewlocki R. cAMP analogs and cholera toxin stimulate the accumulation of nitrite in rat peritoneal macrophage cultures. Eur. J. Pharmacol. 266:1994;125.
26. Ikeda U., Yamamoto K., Icheda M., Ohkawa F., Murata M., Iimura O., Asano Y., Shimada K. Cyclic AMP augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. J. Mol. Cell. Cardiol. 28:1996;789.
27. La Pointe M. C., Sitkins J. R. Mechanisms of interleukin-1β regulation of nitric oxide synthase in cardiac myocytes. Hypertension. 27:1996;709.
28. Mühl H., Kunz D., Pfeilschifter J. Expression of nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP. Br. J. Pharmacol. 112:1994;1.
29. Ikeda U., Kurosaki K., Ohya K., Shimada K. Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells. Cardiovasc. Res. 35:1997;168.
30. Boese M., Busse R., Mülsch A., Schini-Kerth V. Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide sythase in vascular smooth muscle cells: The role of cyclic AMP. Br. J. Pharmacol. 119:1996;707.
31. Oddis C. V., Simmons R. L., Hattler B. G., Finkel M. S. Protein kinase A is required for IL-1-induced nitric oxide production by cardiac myocytes. Am. J. Physiol. 271:1996;C429.
32. Kunz D., Mühl H., Walker G., Pfeilschifter J. Two distinct signaling pathways trigger the expression of inducible nitric oxide sythase in rat renal mesangial cells. Proc. Natl. Acad. Sci. USA. 91:1994;5387.
33. -. Am. J. Physiol. 263:1992;C607.
34. Iimura O., Kusano E., Amemiya M., Muto S., Ikeda U., Shimada K., Asano Y. Dipyridamole enhances interleukin-1β-stimulated nitric oxide production by cultured vascular smooth muscle cells. Eur. J. Pharmacol. 296:1996;319.
35. Scott W. W., McLean S. E., Nakayama D. K. Cyclic GMP is secreted by rat pulmonary artery smooth muscle in response to LPS and IL-1. Am. J. Respir. Crit. Care Med. 155:1997;A635.
36. Liu, S. F. Barnes, P. J. Evans, T. W. Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo, Crit. Care Med. 25, 512, 1997.